SELLAS Life Sciences Group, Inc. SLS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $17.95M+4.4% | $16.02M-16.1% | $15.73M-20.4% | $15.88M-25.1% | $17.19M-21.7% | ||
| —— | —— | —— | —— | —— | ||
| $31.46M+12.6% | $28.27M-10.3% | $26.94M-17.8% | $27.18M-21.9% | $27.93M-22.9% | ||
| -$31.46M-12.6% | -$28.27M+10.3% | -$26.94M+17.8% | -$27.18M+21.9% | -$27.93M+22.9% | ||
| $2.01M+150% | $1.41M+123% | $995K+102% | $924K+153% | $803K+89.4% | ||
| -$29.46M-8.6% | -$26.86M+13.0% | -$25.94M+19.6% | -$26.26M+23.8% | -$27.13M+24.2% | ||
| -$0.23+39.5% | -$0.25+51.9% | -$0.28+59.4% | -$0.32+65.2% | -$0.38+65.5% | ||
| -$31.46M-12.6% | -$28.27M+10.3% | -$26.94M+17.8% | -$27.18M+21.9% | -$27.93M+22.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is SELLAS Life Sciences Group, Inc. profitable?
- SELLAS Life Sciences Group, Inc. is not currently profitable: it reported a net loss of $29.5M over the trailing twelve months, a -4130.1% net margin.
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- Gross margin is 90.0% and operating margin is -4195.0%, with a -4130.1% net margin.
- What is SELLAS Life Sciences Group, Inc.'s earnings per share?
- SELLAS Life Sciences Group, Inc.'s diluted EPS over the trailing twelve months is $-0.23.
- Where does SELLAS Life Sciences Group, Inc.'s income statement data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.